GNPX - Genprex, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.7 -0.08 (-11.03%)	0.0 (0.24%)	0.01 (1.07%)	-0.01 (-1.3%)	-0.03 (-4.86%)	-0.04 (-6.6%)	-0.19 (-22.0%)	-0.18 (-21.29%)

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Market

Earnings & Ratios

Basic EPS:: -0.17
Diluted EPS:
Basic P/E:: -3.6635
Diluted P/E:
RSI(14) 1m:: 52.42
VWAP:: 0.62
RVol:: 0.6511

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.74 +0.02 (+2.14%)	Oct 16 07:56
10m	Price increase 10m	0.72 +0.03 (+3.89%)	Oct 16 07:55
1m	Price increase 1m	0.72 +0.01 (+1.27%)	Oct 16 07:55
1m	Price decrease 1m	0.68 -0.01 (-1.19%)	Oct 16 07:31
60m	Price increase 60m	0.69 +0.04 (+5.35%)	Oct 16 07:29